Provocation After Nurse-Directed Assessment (PANDA) Study
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorThe University of Hong Kong
About this trial
The study aims to evaluate the effectiveness and safety of a collaborative nurse-allergist approach in penicillin allergy delabeling services. It also seeks to assess the impact on patients' quality of life and compare resource utilization and cost-effectiveness between the nurse-allergist collaborative approach and the traditional allergist-led approach.
Eligibility criteria
Qualifiers
Receiving inpatient or outpatient treatment at a participating hospital during the study period;
Possessing a documented penicillin allergy label;
Underwent penicillin allergy evaluation by the nurse-allergist collaborative approach or the traditional allergist-led approach
Demographic and clinical data required for the study available.
Disqualifiers
Patients unable to provide a complete medication history or history of penicillin allergy;
Patients with only emergency or short-term treatment records;
Patients who have taken steroids, antihistamines, or similar medications within the last 3 days.
Trial design
Treatments tested in this trial
- Nurse-led penicillin allergy delabelling service
- Allergist-led penicillin allergy delabelling service
Treatment groups
440 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov